chrisvoncsefalvay/vaers-outcomes huggingface dataset:
prickly feelings; slept all day; felt it right to her stomach; chills; bad anxiety attack; This is a spontaneous report received from a contactable consumer (reporting on herself). A 97-years-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: solution for injection, Lot number: HT6955 and Expiration date was not reported), via an unspecified route of administration in Arm Right on 20Mar2021 11:30 (at the age of 97 years-old) as SINGLE DOSE for covid-19 immunization. Medical history included cardiac murmur, chronic kidney disease, hypertension, blood pressure measurement all from an unknown date and unknown if ongoing. Concomitant medication(s) included atenolol (ATENOLOL) taken for blood pressure measurement from an unspecified start date and ongoing; nifedipine (NIFEDIPINE) taken for blood pressure measurement from an unspecified start date and ongoing; losartan (LOSARTAN) taken for blood pressure measurement from an unspecified start date and ongoing; furosemide (FUROSEMIDE) taken for water pill from an unspecified start date and ongoing; potassium (POTASSIUM) taken for take with the water pill from an unspecified start date and ongoing. It was reported that she got the first shot week ago; clarifies she received the first dose of the Pfizer COVID-19 vaccine on 20Mar2021 at 11:30 in the right arm. States when she got the injection she felt it right to her stomach. The next day she had chills. Patient mentions one night she woke up with a bad anxiety attack in the night, she felt another tiny anxiety attack again yesterday but she told herself you are okay. One day last week she slept all day; and then there was one night were she was just sitting there and she felt prickly feelings all over. Now she was concerned about getting the second shot and was asking how strong was that second shot with regard to her side effects. She called in before to Pfizer the second week to ask about her side effects and left a message for them to call back but no one ever called back. No reference number provided. This will be a follow up. She was planning to receive the second dose on 10Apr2021. Tests: Mentions she recently had an echocardiogram and an EKG but no results are provided.  No follow-up attempts are needed. No further information is expected.
Dose administered more than 12 hours post puncture; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Dose administered more than 12 hours post puncture) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025D21A) for COVID-19 vaccination.     No Medical History information was reported.    On 23-Oct-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Oct-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Dose administered more than 12 hours post puncture). On 23-Oct-2021, EXPIRED PRODUCT ADMINISTERED (Dose administered more than 12 hours post puncture) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Patient was administered with vaccine on 23-oct-2021,which was punctured on 22-oct-2021.It was stored in refrigerator on 14Oct2021 at 44 F. Concomitant medications were not provided. Treatment information was not provided.
Patient here for second dose of Pfizer vaccine. Post vaccine within the first 5 minutes, patient was noted to have altered level of consciousness (possible syncope) with noted body movements. Patient came back to mental baseline within a few seconds. No post ictal state. Patient able to ambulate from chair to gurney with minimal assist. Reported oral intake since 08:00 this morning. Patient provided with snack and juice and tolerated PO intake well. Evaluated by NP and discussed case with clinic MD. Patient ambulated home post consult/discussion with NP and MD. No post ictal state noted, no incontinence of bowel or bladder.
Patient's caregiver called reporting that patient received 3 vaccines 3 days ago and believes she is having a reaction. She reports the patient as being disoriented, with the inability to write a check or open her phone. She wasn't sure if the patient was eating or drinking as usual. She reports that the patient isn't experiencing any flu like symptoms. The symptoms started today, 2 days after receiving the vaccine. She was unable to provide any additional information as she wasn't with the patient during the phone call. After the call, I immediately called the phone number we have on file to reach the patient for a follow up and to gather additional information. A male caregiver answered the phone and informed us that he believed she was having side effects from receiving 3 vaccines. He reports that the patient had blurry vision today and was disoriented. She was eating and drinking normally, but wasn't feeling well. He reported that she did eat food today and took her insulin and reports that her sugar level was 77.  Advised caregivers to have patient follow up with a physician.
3 days after taking 2nd dose of covid vaccine developed chills, headache, nausea, vomiting, bodyache, joint swelling, rash and itching all over body.
headache, dizziness and  nausea. Treatment: Allegra D for dizziness  x 1 /day for 3 days ongoing                              Zofran for nausea PRN ongoing
tested positive with covid.  first symptoms on 12/28/21 most likely effected date 12/23/21. tested on 1/06/22 results of positive received 1/07/22. symptoms lasted until 1/09/22. sore throat left side first couple days with fever starting next day. lasted a few days then fever went away and sore throat was almost gone for about 16 hours. lymph node on right side of throat swelled up and fever returned even worse. fever lasted few days. after lymph node swole. throat got sore on right side as well. once fever was gone for 2 days I got hives on legs on butt area some in other areas, both palms got very red swollen and itchy lasted about 16 hours. felt better for about 12 hours then left side lymph nodes in neck started swelling and hives returned very quickly. hives lasted about 12 hours then very quickly went away all at once. lymph node in neck right side no longer is swollen and slight swelling on left side as of 1/11/2022
Fever of 100-100.4; tired; headache; achey; loss of appetite; This is a spontaneous report from a non-contactable consumer (patient) in response to non-HCP letter sent in cross-reference case. A 72-years-old patient of an unspecified gender received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Batch/Lot Number: SN6205, patient was 72-yeear-oldat the time of vaccination), via intramuscular route of administration, administered in Arm Left on 03Mar2021 at 09:30 as DOSE 2, SINGLE for covid-19 immunisation. The patient's medical history included migraine and Hashimoto. Concomitant medication(s) included diclofenac (DICLOFENAC) taken for migraine from an unspecified start date and ongoing 2 days prior; levothyroxine sodium (SYNTHROID) taken for autoimmune thyroiditis from an unspecified start date and ongoing; liothyronine sodium (CYTOMEL) taken for autoimmune thyroiditis from an unspecified start date and ongoing. Historical vaccine included first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Batch/Lot Number: EL9624), via intramuscular route of administration, administered in Arm Left on 10Feb2021 at 08:22 AM as DOSE 1, SINGLE for covid-19 immunisation and experienced hot/cold, achy, tired, headache, fever all on 11Feb2021 for 4 days with outcomes of events were recovered without any treatment. No prior Vaccinations received. On 03Mar2021, the patient experienced fever of 100-100.4, tired, headache, achey, loss of appetite for 5 days (Outcome unknown for events). The patient underwent lab tests and procedures which included body temperature: 100 - 100.4 on 03Mar2021, sars-cov-2 test: negative on 05Mar2021. No treatment received for Fever and required urgent care on 05Mar2021. The outcome of event (fever of 100-100.4) was recovered on an unspecified date in 2021 and the outcomes of events (tired, headache, achey, loss of appetite) were unknown.  No follow-up attempts are possible. Information about lot/batch number cannot be obtained. No further information is expected.
No additional adverse events reported; improperly stored vaccines were potentially administered to unknown patients; This spontaneous report has been received from a licensed practical nurse, referring to a patient of unknown age and gender. No information regarding the patient's pertinent medical history, drug reactions or allergies and concomitant therapies was provided.    On 30-DEC-2021, the patient was vaccinated with improperly stored hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) (lot # T025370 with expiration date: 01-DEC-2022 (also reported as 01-FEB-2022), route, strength and dose were unknown) for prophylaxis (Product storage error). No additional adverse events reported.  Administered dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) experienced the temperature excursion below 49.6 Fahrenheit degrees (F) for 35 hours 9 minutes. The previous temperature excursions were reported as 32.9F for 53 hours 16 minutes; 49. 1F for 5 hours 9 minutes; 56.3F for 14 hours 7 minutes.  This is one of several reports received from the same reporter.   ; Sender's Comments:  US-009507513-2203USA003310: US-009507513-2203USA003311: US-009507513-2203USA003312: US-009507513-2203USA003313: US-009507513-2203USA003314: US-009507513-2203USA003315: US-009507513-2203USA003316: US-009507513-2203USA003317: US-009507513-2203USA003318: US-009507513-2203USA003319: US-009507513-2203USA003320: US-009507513-2203USA003321: US-009507513-2203USA003322: US-009507513-2203USA003323: US-009507513-2203USA003324: US-009507513-2203USA003325: US-009507513-2203USA003326: US-009507513-2203USA003327: US-009507513-2203USA003328: US-009507513-2203USA003329: US-009507513-2203USA003330: US-009507513-2203USA003331: US-009507513-2203USA003332: US-009507513-2203USA003333: US-009507513-2203USA003335: US-009507513-2202USA003592:
Intense headaches for 2 weeks off and on throughout the day.; Fatigue; Joint pain; Depression; Body aches; This is a spontaneous report from a contactable healthcare professional, the patient. A 49-year-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8734) via an unspecified route of administration in the left arm on 31Mar2021 at 13:30 (at the age of 49-years-old) as a single dose for COVID-19 immunisation. Medical history included allergy to penicillin. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications were not reported. On 01Apr2021 at 00:00, the patient experienced intense headaches for 2 weeks off and on throughout the day, that got better but still battling with frequent headaches. The patient also reported for fatigue, joint pain, depression and body aches. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events intense headaches for 2 weeks off and on throughout the day, fatigue, joint pain, depression and body aches was resolved with sequelae on an unknown date Apr2021.  No follow-up attempts are needed. No further information is expected.
Patient's husband called concerned patient was having chills, muscle, and joint pain starting on the morning after receiving vaccination. Also having pain and redness at injection site. Told patient to see healthcare provider.
Escalation of long-standing Tinnitus ... much louder and constant high whine/ringing in both ears.  Will be consulting with ENT.  Concerned about getting second dose.
itchiness; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a patient and describes the occurrence of PRURITUS (itchiness) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRURITUS (itchiness). The patient was treated with ACRIVASTINE (BENADRYL ALLERGY RELIEF) for Itching, at an unspecified dose and frequency. At the time of the report, PRURITUS (itchiness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Severe shoulder pain and upper arm pain. Restricted range of motion. Prior to vaccine had zero issues with shoulder. Arm was sore and kept getting worse each day...shoulder pain began around day 3. Continually got worse. Affected sleeping, anything to do with arm and shoulder usage, woke me up twice a night. In the morning when I got up, pain so severe I could not lift shoulder out of position without assistance. Pain was all day and all night. Pain is severe up still and range of motion affected.
This case was reported by a pharmacist via call center representative and described the occurrence of suspected vaccination failure in a adult patient who received SHINGRIX for prophylaxis. Co-suspect products included SHINGRIX for prophylaxis. The patient's past medical history included shingles. On an unknown date, the patient received SHINGRIX at an unknown dose and the 2nd dose of SHINGRIX. On an unknown date, unknown after receiving SHINGRIX and SHINGRIX, the patient experienced vaccination failure (serious criteria GSK medically significant), shingles and shingles. (Dechallenge was negative). Rechallenge with SHINGRIX was positive. On an unknown date, the outcome of the vaccination failure, shingles and shingles were unknown. It was unknown if the reporter considered the vaccination failure, shingles and shingles to be related to SHINGRIX. It was unknown if the reporter considered the vaccination failure and shingles to be related to SHINGRIX. Additional information was reported as follows: The age at vaccination was not reported. The age group was not reported, but was captured as adult as per the vaccine indication. The patient had a history of shingles and had experienced a flair up of shingles after the first dose and the 2nd dose. The reporter did not consent to follow-up. The healthcare professional had not provided any adverse event information and did not wanted to be contacted regarding the adverse event. This case was considered for suspected vaccination failure as the exact time to onset for the event was unknown.
On Oct 22nd 2001 pt's mother noted pink line across left thigh. Then it became a pink spot with a high temperature of 104.5 F. Had low grade fever following day of vaccination.
Rapid heart rate Started at 10:00pm day of injection, and continues still. Visit to primary MD, Specialist and labs for bloodwork
Patient received the shingles vaccination through a visit to his PCP for a wellness visit on 7/30/2015 around 0900. Local rxn of itching focal redness and firmness noted the following day, increasing redness soreness to injection site continued 8/1/2015 8/2/15 Presented to me for eval. (L) arm tricep area showed 3cm red, indurated area with a 19cm x 12cm wide area of redness. Function well intact. No SOB. No systemic issues.
Felt bad for 6 days; Soreness; L arm egg raised ball; Itchy; Redness; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Itchy), ERYTHEMA (Redness), VACCINATION SITE REACTION (L arm egg raised ball), FEELING ABNORMAL (Felt bad for 6 days) and PAIN (Soreness) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 040A21A and 007M00A) for COVID-19 vaccination.     Concurrent medical conditions included Depression, Blood pressure abnormal and Hypercholesterolaemia. Concomitant products included PROPRANOLOL from 26-Mar-2021 to an unknown date for Blood pressure management, AMITRIPTYLINE HYDROCHLORIDE (AMITRIPTYLINE [AMITRIPTYLINE HYDROCHLORIDE]) from 08-Mar-2020 to an unknown date for Depression, ATORVASTATIN from 04-Apr-2020 to an unknown date for Hyperlipidemia, ATENOLOL, CALCIUM, VITAMIN E NOS, VITAMIN D3, ASCORBIC ACID (VITAMIN C ASC ACID), CYANOCOBALAMIN (VITAMIN B12 [CYANOCOBALAMIN]), ACETYLSALICYLIC ACID (ASPIRIN ANALGESIC), UBIDECARENONE (COQ10 [UBIDECARENONE]), VITAMIN B NOS (B-COMPLEX [VITAMIN B NOS]), GARLIC [ALLIUM SATIVUM] and AIRBORNE for an unknown indication.   On 17-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 21-Mar-2021, the patient experienced PRURITUS (Itchy) and ERYTHEMA (Redness). On 22-Mar-2021, the patient experienced VACCINATION SITE REACTION (L arm egg raised ball). On an unknown date, the patient experienced FEELING ABNORMAL (Felt bad for 6 days) and PAIN (Soreness). On 29-Mar-2021, VACCINATION SITE REACTION (L arm egg raised ball) had resolved. At the time of the report, PRURITUS (Itchy), ERYTHEMA (Redness) and PAIN (Soreness) had resolved and FEELING ABNORMAL (Felt bad for 6 days) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Other Concomitant medication include Airborne. Treatment information included Ice packs.  Patient had big red itchy lump on left arm went to physician they said to keep an eye on it was about the size of 3 inches in diameter.   Upon internal review on 06 Jul 2021, medical history was updated.  Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.  ?   This case was linked to MOD-2021-135872 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 16-May-2021: Additional information received and Patient demographics were updated and medical history includes Depression Blood Pressure, Cholesterol were added.Dose 2 details were added.Concomitant product information was updated.Event Left arm egg raised ball,felt bad for 6 days were added On 20-Jul-2021: Event Soreness was added
Day of vaccine did not feel well afterward. Next day - red lump at shot site. Following day - red bump the size of quarter and redness size of tennis ball.
Patient presents to the clinic a week after receiving Prevnar 20 vaccine with complaints of redness, swelling, pain, and rash at the injection site.  Patient prescribed triamcinolone acetonide to treat symptoms of the reaction.
The patient was given this vaccine 15 days after the beyond use date. The clinic is currently working on creating guidelines and processes to prevent this from happening again.
05/18/2022 vaccination. 06/06/2022 were exposed to COVID. My partner was away and was exposed. When he arrived that night, he had a bit of a sniffle. 06/08/2022 found out he was exposed. 06/09/2022 I tested positive and contacted my Dr. It took a week for Dr. to contact me back. I was 'ok' they didn't contact me back as I wasn't feeling too poorly. I had some post-nasal gunk, sneezing. I had talked with a nurse and somehow the communication got dropped. 06/16/2022 Spoke to Dr. I thought I was 'fine'. I had gone to the hotel room to see my partner. Somehow I ended up having a relapse. 06/17/2022 I was still testing positive. I continued isolation. Sniffles, post nasal drip, sneezing. 06/21/2022 I tested COVID.
Information has been received from a consumer concerning her 73 year old male husband with a pacemaker and a defibrillator, and a history of both knees and hips replaced; who on 02-JAN-2008 was vaccinated with a dose of ZOSTAVAX (Oka/Merck). It was reported that the patient was on therapy with other unspecified medications. Around the first week of November 2008, the patient experienced pain in his hip and by mid-November developed the shingles. Patient had received two nerve blocks to help with the pain associated with the shingles. The patient sought unspecified medical attention. At the time of reporting, the patient's outcome was unknown. Additional information has been requested.
Next day resident developed a large warm, red, raised area approximately the size of a softball. Resident started it was painful. treated per orders of PCP with  Benadryl 50 mg q6h PRN X 48 hours, apply cold compress PRN, IBU600mg BID X 3 days.
Fever; Chills; Muscle pain; Daughter broke out rash form head to toe; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever), CHILLS (Chills), MYALGIA (Muscle pain) and RASH (Daughter broke out rash form head to toe) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PYREXIA (Fever), CHILLS (Chills), MYALGIA (Muscle pain) and RASH (Daughter broke out rash form head to toe). At the time of the report, PYREXIA (Fever), CHILLS (Chills), MYALGIA (Muscle pain) and RASH (Daughter broke out rash form head to toe) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication not reported.  Treatment medication not reported.   This case was linked to US-MODERNATX, INC.-MOD-2021-059071 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-059071:Crosslinked with Daughter husband case
fever of 103 @ home on 21NOV in afternoon gave APAP & fever came down to 101;fever back up to 104.9;22NOV morning went to ER;22NOV evening they had rectal temp of 106;given motrin & APAP, IV drip & ATB, fever down to nl by sunday noc 10PM;
pt recv vax 8MAY98 & devel hives, SOB, aching joints, severe fatigue, swelling in extremities cont 4-5wk period still has reoccurrences 3mo later;
Shortness of breath starting around 7/2021, Coughing & Chest Pain started around 4/2022.  Diagnosed with Sarcoidosis / Moderate COPD in 12/2021.  No medication required to date.  Follow-up CT Scan and Pulmonary Function Test in 6/2022.
pt recv vax 20AUG98 & pt exp rash which was described as red, itchy & blotchy;
At 6:01 pm om 9/30/2015, patient contacted vaccine provider telling him that he was experiencing extreme shoulder pain at the injection site. Both his shoulder and arm hurt. He contacted his doctor. His doctor told him to take OTC pain reliever BENADRYLL and apply ice.
No additional AE reported.; Patient was administered Improperly Stored, Separate PNEUMOVAX 23; This spontaneous report has been received from an office manager and refers to a patient of unknown age and gender. There was no information regarding the patient's medical history, concurrent conditions and concomitant medication provided.  On 27-DEC-2022, the patient was vaccinated with an improperly stored dose of pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX 23) injection, lot # W007035 confirmed to be valid with expiration date 23-OCT-2023 (exact dose, dose number, route of administration and anatomical location were not reported), for prophylaxis (product storage error). There was no additional adverse event reported.  On 23-DEC-2022, the administrated dose of the suspect vaccine underwent a temperature excursion of 55 Fahrenheit degrees for 153 hours. There was no previous temperature excursion.
Body aches, headaches, chills, body very hot, lots of soreness in arm of injected site, arm ache on other arm after a day as well